Immunome Q4 Adj EPS $(0.15) Beats $(0.28) Estimate, Sales $3.83M Beat $2.07M Estimate
Immunome Q4 Adj EPS $(0.15) Beats $(0.28) Estimate, Sales $3.83M Beat $2.07M Estimate
Immunome第四季度调整后每股收益美元（0.15美元）超过预期（0.28美元），销售额383万美元超过207万美元的预期
Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 46.43 percent. This is a 76.56 percent increase over losses of $(0.64) per share from the same period last year. The company reported quarterly sales of $3.83 million which beat the analyst consensus estimate of $2.07 million by 84.83 percent.
Immunome（纳斯达克股票代码：IMNM）公布的季度亏损为每股0.15美元，比分析师普遍预期的0.28美元（0.28美元）高出46.43个百分点。这比去年同期每股亏损0.64美元（0.64美元）增长了76.56％。该公司公布的季度销售额为383万美元，比分析师普遍预期的207万美元高出84.83％。